Yung H. Son, MD Yung H. Son, MD, is Director of Head and (continued): Neck Radiation Oncology. As Professor in the Department of Therapeutic Radiology, David Leffell, MD, Professor of Dermatology and Professor he is well recognized nationally and of Surgery in Otolaryngology and Plastic. CEO of the Yale internationally for his innovations in the Medical Group, Deputy Dean for Clinical Affairs at Yale management of Head and Neck Cancer. His School of Medicine, Chief, Section of Dermatologic Surgery contributions in the use of Brachytherapy (radiation seed and Cutaneous Oncology. implants) have spearheaded the organ-sparing mission of our Roger A. Lowlicht, MS, DDS, Associate Clinical Professor, Head and Neck Cancer Program. Yale Otolaryngology. William H. Rosenblatt, MD, Associate Professor of Nwanmegha Young, MD Anesthesiology and Otolaryngology, Chief of Head and Dr. Nwanmegha Young’s clinical expertise Neck Anesthesiology. lies in the medical and surgical treatment of voice disorders, including care of the Yale Head and Neck performing voice. Dr. Young is an expert in the diagnosis of neurologic disorders of the SUPPORT GROUP FOR THOSE COPING larynx and treatment with botulinum. Cancer Program WITH HEAD & NECK CANCER Dr. Young received his undergraduate degree from University of California at Berkeley, and his MD from the University of Where: Smilow Cancer Center California at Davis. Following medical school he completed his 35 Park Street residency in Otolaryngology - Head & Neck Surgery at www.yaleheadandneck.org CH 290 / West Pavilion Washington University Barnes Jewish Medical Center. He then New Haven, CT 06519 pursued a fellowship in laryngology at the New York Center for Voice and Swallowing Disorders under the guidance of Dr. For: Anyone who is coping with Head & Neck Cancer, Andrew Blitzer. There he also has worked with Dr. Anthony including friends and family members The Yale Head and Neck Program is Jahn, Medical Director of Lincoln Center and the New York composed of highly dedicated physicians rd Metropolitan Opera. When: Every 3 Thursday of the Month and surgeons joined by a skilled team of (except holidays) rehabilitation specialists in speech, swallowing and hearing restoration. All Additional faculty in our Program: Time: 3 pm – 4:30 pm, walk-ins welcomed physicians are board certified and James J. Abrahams, MD, Professor, Yale Diagnostic fellowship trained. As part of the Yale Please register by contacting: Cancer Center, the team offers expert care Radiology and Otolaryngology and Director of Medical Jessica Shore, MSW, LCSW, 203-200-6358 Studies for the Radiology Department. for tumors of the skull base and other or malignancies of the head and neck. A Stephan Ariyan, MD, Clinical Professor, Yale Plastic Bryan Sperrazza, RN, 203-737-4230 collaborative approach to care includes Surgery and Otolaryngology. Bryan.Sperrazza@ynhh.org Otolaryngology, Medical Oncology, Plastic Surgery, Neurosurgery, Dermatology, David S. Fischer, MD, Clinical Professor, Medical Radiation Therapy, Head and Neck Oncology Radiology and Oral Surgery, thus offering Gary E. Horblitt, DDS, Assistant Clinical Professor, Yale Yale Head and Neck Cancer Program the most effective of treatment options for Otolaryngology. Yale Physicians Building diseases affecting the ear, sinuses, larynx th 800 Howard Ave, 4 Floor and pharynx, while emphasizing the organ- Michele H. Johnson, MD, Director of Interventional New Haven, CT 06519 sparing mission of the Yale Cancer Center. Neuroradiology, Associate Professor of Yale Diagnostic Radiology and Otolaryngology. Phone: 203-785-2593 Fax: 203-785-3970 This program is grateful for the Diane P. Kowalski, MD, Assistant Professor and Director of the Fine Needle Aspiration Biopsy Service in the charitable support provided by Virginia Alden Wright Family. Department of Pathology www.yaleheadandneck .org Hari D. Deshpande, MD Elias Michaelides, MD MEET THE TEAM Hari A. Deshpande, MD, is an Assistant Professor of Medical Oncology whose clinical Elias Michaelides, MD, is an Assistant Professor of Surgery in the Section of Otolaryngology. He is a neurotologist and interest includes Head and Neck Cancers and skull base surgeon who provides support Prostate Cancer. He is currently the principal Clarence T. Sasaki, MD for lateral skull base tumors. He received or co-investigator on many of the clinical trials Clarence T. Sasaki, MD, Director of the a BA from Cornell University and his MD at the cancer center. Some of these are Head and Neck Tumor Board, is the from SUNY-Stony Brook. He completed a residency in evaluating the use of new agents previously never used in this Charles W. Ohse Professor of Surgery Otolaryngology-Head and Neck Surgery at the Medical disease type. He has had papers published in the British Journal and the Chief of Otolaryngology – College of Virginia, before completing a Fellowship in of Hematology and The Cancer journal of Scientific American. Head and Neck Surgery at the Yale Otology, Neurotology and Skull Base Surgery at the Michigan He received his medical degree from Leeds University Medical School of Medicine. He received his Ear Institute. Dr. Michaelides provides comprehensive care School, Leeds, England. He completed his Hematology and BA from Pomona College in 1962 and his MD from Yale of skull base tumors and other tumors of the ear and Oncology Fellowship at the Montefiore Medical Center in in 1966. He completed his residency at the Yale-New temporal bone. Bronx, NY. As an active member of the Head and Neck Tumor Haven Medical Center in 1973 and has completed three Board, Dr. Deshpande believes that the newer clinical fellowships: 1) International Union Against chemotherapeutic and targeted agents will play an increasingly Daniel Morgensztern, MD Cancer with Professor Ettore Bocca, Milan, Italy, 1978. important role in the treatment of this disease. Often the side 2) International Union Against Cancer with Professor Daniel Morgensztern, MD, is an Assistant effects of the newer treatments are less than traditional Professor of Medical Oncology Ugo Fisch, Zurich, Switzerland, 1982. 3) International chemotherapy and the response rates are so far encouraging. Union Against Cancer with Mr. Dai Davis, London, specializing in the treatment and care of patients with lung and head and neck England, 1986. Benjamin L. Judson, MD cancers. He is an integral member of the Benjamin L. Judson, MD, is an Assistant Yale Cancer Center and Smilow Cancer Hospital. Dr. Morgensztern received his medical degree Professor of Surgery at the Yale School of Mark Bianchi, MD from Fundacao Tecnico-Educacional Souza Marques in Medicine specializing in the treatment of benign Mark Bianchi, MD, is an Assistant Professor Brazil. He completed his internship, residency, and and malignant tumors of the head and neck. He of Surgery in Yale Otolaryngology and is the fellowship in hematology/oncology at the University of attended Middlebury College as an Director of the Medical Student Rotation. Miami. He is the recipient of an American Society of Clinical undergraduate, obtained a masters degree from He received his MD from Yale University Oncology Young Investigator Award and Merit Award. the University of Pennsylvania, and graduated from Jefferson and Residency at Yale-New Haven Medical Medical College. He completed a residency in Otolaryngology - Center. He is building a strong Rhinology Head & Neck Surgery at Georgetown University Hospital before Manju L. Prasad, MBBS, MD and Endoscopic Skull Base Surgery Program. He has an completing a fellowship in Head and Neck Surgical Oncology at Manju L Prasad, MBBS, M.D. is Associate interest in sialoendoscopy and the use of ultrasound in ENT. Memorial Sloan-Kettering Cancer Center. He has a broad clinical Professor of Pathology specializing in head Dr. Bianchi also serves as Chief of Otolaryngology at interest in treating head and neck cancers as part of a and neck, and endocrine Pathology. She Bridgeport Hospital. multidisciplinary team. His clinical focus includes treating cancers graduated from the Institute of Medical of the oral cavity, pharynx and larynx, salivary tumors, skin Sciences at the Banaras Hindu University, cancers, and sinonasal tumors. Varanasi, India. Dr. Prasad completed Roy Decker, MD, PhD residency in Pathology at the New York Presbyterian Dr. Roy Decker, MD, PhD, is an Assistant R. Peter Manes, MD Hospital of Cornell University. Subsequently, she completed Professor of Therapeutic Radiology and two years of Oncologic Surgical Pathology Fellowship at the R. Peter Manes, MD, is an Assistant Professor of Otolaryngology. He received his BA from Memorial Sloan-Kettering Cancer Center that included one Surgery at the Yale School of Medicine, the University of Virginia and his MD and year of Head and Neck pathology. Her areas of interest specializing in nasal and sinus tumors. He PhD from the Medical College of Virginia. include tumors of the head and neck including thyroid, attended Georgetown University and received He fulfilled his residency in Radiation parathyroid, adrenal gland, bone and soft tissue. Dr. Prasad his medical degree from Albany Medical Oncology at Hospital. His clinical interest is Oncology at Yale-New Haven Yale-New Haven Hospital. is the director of the Immunohistochemistry Laboratory, College. After completing a residency in Oto- in Image-Guided, Intensity Modulated Radiation Therapy and the Endocrine, Head and Neck Subspeciality Program in laryngology - Head and Neck Surgery at Georgetown University (IGRT, IMRT) for head and neck cancer. His primary research Pathology. She is part of the multidisciplinary teams at Yale Hospital, he completed a fellowship in rhinology and endoscopic focus is on molecular biomarkers of radiation response, and that treat cancers of the head and neck region, and skull base surgery at the University of Texas Southwestern combining chemotherapy and targeted agents with endocrine systems. Medical Center. His clinical interests include minimally invasive, radiotherapy for patients with high-risk head & neck cancer. endoscopic treatments of nasal and sinus tumors.